Health In Tech Earnings Call Transcripts
Fiscal Year 2026
-
Q1 2026 revenue grew 9% to $8.8M, with a net loss of $1.6M as investments in sales, tech, and distribution accelerated. Full-year revenue guidance of $45–$50M was reiterated, and new platform features and products are driving positive broker feedback and future growth.
Fiscal Year 2025
-
Revenue grew 71% to $33.3M in 2025, driven by distribution and platform expansion, with adjusted EBITDA up 81%. 2026 guidance targets $45M–$50M revenue, supported by new large employer offerings, AI investments, and a three-year rate stabilization program.
-
Q3 2025 saw 90% revenue growth year-over-year, driven by expanded distribution and new large employer solutions. Adjusted EBITDA and pre-tax income rose sharply, with full-year revenue expected to grow 70%. Blockchain and AI initiatives, plus a three-year rate hold program, position the company for continued momentum.
-
A digital insurtech platform leverages AI to streamline healthcare plan selection for small businesses, achieving rapid revenue and EBITDA growth while expanding nationwide. The company claims unique competitive advantages, a robust partner network, and targets sustained 50% YoY growth.
-
Q2 2025 revenue surged 86% year-over-year to $9.3M, with strong profitability and cash flow. Strategic partnerships and technology innovation are driving rapid expansion, with new products and the iCard relaunch set to fuel future growth.
-
Q1 2025 saw 56% revenue growth and a 257% increase in pre-tax income, driven by strong platform demand, expanded broker network, and the beta launch of an AI-powered underwriting solution. Gross margin was 66.8%, and the company expects continued momentum into Q2.
Fiscal Year 2024
-
Achieved modest revenue growth in 2024 with a strategic shift to higher program fees and significant investments in technology, leadership, and cybersecurity. Entering 2025 with strong momentum, unaudited revenue for the first two months already exceeds last year's Q1 total.